{
  "metrics": {
    "totalTests": 10,
    "correctDecisions": 0,
    "accuracy": 0,
    "consistencyRate": 0,
    "jsonValidRate": 1,
    "avgConfidence": 0,
    "needReviewRate": 1,
    "confusionMatrix": {
      "truePositive": 0,
      "falsePositive": 0,
      "trueNegative": 0,
      "falseNegative": 0,
      "uncertain": 0
    }
  },
  "results": [
    {
      "literatureId": "test-001",
      "title": "Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial",
      "expectedDecision": "include",
      "actualDecision": "error",
      "isCorrect": false,
      "hasConsensus": false,
      "needReview": true,
      "avgConfidence": 0,
      "deepseekResult": null,
      "qwenResult": null,
      "processingTime": 8868
    },
    {
      "literatureId": "test-002",
      "title": "Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes",
      "expectedDecision": "include",
      "actualDecision": "error",
      "isCorrect": false,
      "hasConsensus": false,
      "needReview": true,
      "avgConfidence": 0,
      "deepseekResult": null,
      "qwenResult": null,
      "processingTime": 7365
    },
    {
      "literatureId": "test-003",
      "title": "Systematic Review and Meta-Analysis of SGLT2 Inhibitors in Type 2 Diabetes: A Comprehensive Assessment",
      "expectedDecision": "exclude",
      "actualDecision": "error",
      "isCorrect": false,
      "hasConsensus": false,
      "needReview": true,
      "avgConfidence": 0,
      "deepseekResult": null,
      "qwenResult": null,
      "processingTime": 8163
    },
    {
      "literatureId": "test-004",
      "title": "Dapagliflozin Improves Cardiac Function in Diabetic Rats: An Experimental Study",
      "expectedDecision": "exclude",
      "actualDecision": "error",
      "isCorrect": false,
      "hasConsensus": false,
      "needReview": true,
      "avgConfidence": 0,
      "deepseekResult": null,
      "qwenResult": null,
      "processingTime": 12106
    },
    {
      "literatureId": "test-005",
      "title": "Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy",
      "expectedDecision": "include",
      "actualDecision": "error",
      "isCorrect": false,
      "hasConsensus": false,
      "needReview": true,
      "avgConfidence": 0,
      "deepseekResult": null,
      "qwenResult": null,
      "processingTime": 4700
    },
    {
      "literatureId": "test-006",
      "title": "Real-World Experience with SGLT2 Inhibitors: A Retrospective Cohort Study",
      "expectedDecision": "exclude",
      "actualDecision": "error",
      "isCorrect": false,
      "hasConsensus": false,
      "needReview": true,
      "avgConfidence": 0,
      "deepseekResult": null,
      "qwenResult": null,
      "processingTime": 7922
    },
    {
      "literatureId": "test-007",
      "title": "Pharmacokinetics and Pharmacodynamics of Empagliflozin in Healthy Volunteers",
      "expectedDecision": "exclude",
      "actualDecision": "error",
      "isCorrect": false,
      "hasConsensus": false,
      "needReview": true,
      "avgConfidence": 0,
      "deepseekResult": null,
      "qwenResult": null,
      "processingTime": 7877
    },
    {
      "literatureId": "test-008",
      "title": "Comparative Effectiveness of SGLT2 Inhibitors versus DPP-4 Inhibitors in Elderly Patients with Type 2 Diabetes",
      "expectedDecision": "exclude",
      "actualDecision": "error",
      "isCorrect": false,
      "hasConsensus": false,
      "needReview": true,
      "avgConfidence": 0,
      "deepseekResult": null,
      "qwenResult": null,
      "processingTime": 11004
    },
    {
      "literatureId": "test-009",
      "title": "Severe Diabetic Ketoacidosis Associated with SGLT2 Inhibitor Use: A Case Report",
      "expectedDecision": "exclude",
      "actualDecision": "error",
      "isCorrect": false,
      "hasConsensus": false,
      "needReview": true,
      "avgConfidence": 0,
      "deepseekResult": null,
      "qwenResult": null,
      "processingTime": 11130
    },
    {
      "literatureId": "test-010",
      "title": "Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment",
      "expectedDecision": "uncertain",
      "actualDecision": "error",
      "isCorrect": false,
      "hasConsensus": false,
      "needReview": true,
      "avgConfidence": 0,
      "deepseekResult": null,
      "qwenResult": null,
      "processingTime": 7387
    }
  ]
}